Anixa Biosciences Inc (ANIX)
2.85
-0.06
(-2.06%)
USD |
NASDAQ |
May 17, 16:00
2.86
+0.01
(+0.35%)
After-Hours: 20:00
Anixa Biosciences Market Cap: 90.91M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 90.91M |
| May 16, 2024 | 92.83M |
| May 15, 2024 | 93.47M |
| May 14, 2024 | 95.06M |
| May 13, 2024 | 94.74M |
| May 10, 2024 | 95.70M |
| May 09, 2024 | 91.55M |
| May 08, 2024 | 96.34M |
| May 07, 2024 | 92.83M |
| May 06, 2024 | 96.34M |
| May 03, 2024 | 93.79M |
| May 02, 2024 | 94.74M |
| May 01, 2024 | 98.57M |
| April 30, 2024 | 94.74M |
| April 29, 2024 | 96.34M |
| April 26, 2024 | 103.04M |
| April 25, 2024 | 95.06M |
| April 24, 2024 | 101.44M |
| April 23, 2024 | 97.93M |
| April 22, 2024 | 96.02M |
| April 19, 2024 | 99.53M |
| April 18, 2024 | 98.89M |
| April 17, 2024 | 97.29M |
| April 16, 2024 | 101.12M |
| April 15, 2024 | 100.80M |
| Date | Value |
|---|---|
| April 12, 2024 | 101.12M |
| April 11, 2024 | 102.72M |
| April 10, 2024 | 102.08M |
| April 09, 2024 | 103.67M |
| April 08, 2024 | 101.12M |
| April 05, 2024 | 102.08M |
| April 04, 2024 | 100.17M |
| April 03, 2024 | 104.63M |
| April 02, 2024 | 102.08M |
| April 01, 2024 | 106.86M |
| March 28, 2024 | 99.53M |
| March 27, 2024 | 103.04M |
| March 26, 2024 | 99.85M |
| March 25, 2024 | 103.04M |
| March 22, 2024 | 110.37M |
| March 21, 2024 | 117.71M |
| March 20, 2024 | 118.99M |
| March 19, 2024 | 114.84M |
| March 18, 2024 | 111.97M |
| March 15, 2024 | 117.71M |
| March 14, 2024 | 98.25M |
| March 13, 2024 | 101.44M |
| March 12, 2024 | 98.25M |
| March 11, 2024 | 102.57M |
| March 08, 2024 | 103.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.36M
Minimum
Mar 27 2020
190.68M
Maximum
Mar 17 2021
102.07M
Average
100.92M
Median
Jan 13 2021
Market Cap Benchmarks
| CEL-SCI Corp | 68.78M |
| AIM ImmunoTech Inc | 20.11M |
| IGC Pharma Inc | 35.69M |
| NovaBay Pharmaceuticals Inc | 4.487M |
| Protalix BioTherapeutics Inc | 83.58M |
Market Cap Related Metrics
| Price to Book Value | 3.695 |
| Price | 2.85 |
| Earnings Yield | -11.93% |